Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kidney Associated Antigen 1 (KAAG1) is a protein encoded by the KAAG1 gene, found on chromosome 6 in humans. While classified as a long non-coding RNA, the KAAG1 gene produces a protein product. It is highly expressed in the testis and kidney, with lower expression in the bladder and liver. KAAG1 is overexpressed in various tumor types, including melanomas, sarcomas, colorectal carcinomas, and ovarian cancer. Bioinformatic analysis suggests that KAAG1 is a membrane-associated or secreted protein, making it a potential target for antibody-based therapies like antibody-drug conjugates (ADCs). It may be involved in cellular processes specific to kidney function and potentially interacts with the MAPK pathway.
Antibody-drug conjugates (potential)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kidney Associated Antigen 1 (KAAG1).